SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Reports that SpaceX is seeking substantial financing to buy Nvidia chips for its AI buildout are driving debate: some traders see the borrowing and capital needs as a debt and valuation risk, while others view it as investment in future growth. Concerns about an upcoming share unlock add to near-term caution.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists five-year patent-licensing and settlement agreement with Micron, which ends their pending legal disputes and provides recurring licensing revenue, drove the sharp share move. Traders largely welcomed the deal as validation of Netlists memory patents, while some questioned its terms and viewed potential SK Hynix or Google agreements as future, uncertain catalysts.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

A rebound in Amazon shares has traders watching for a technical breakout, with bullish posts pointing to improving momentum and bearish ones wary of the stocks repeated intraday fades and lagging performance. Discussion also reflects optimism around AWS and AI growth ahead of earnings, balanced by concerns over heavy investment spending.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is drawing attention after reporting a quarterly earnings beat and raising its fiscal 2027 outlook, citing strength in AI infrastructure and memory demand tied to data-center growth. The reaction is largely bullish, though traders are debating whether the strong results will sustain the rally or be met with profit-taking and resistance.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy surged after signing a 20-year Google power agreement that supports 890 MW of added nuclear capacity and includes a separate long-term supply contract, reinforcing expectations that AI data-center demand will boost the value of reliable electricity. Traders broadly welcomed the deal as a catalyst for CEG and the wider power sector, while some flagged profit-taking and uncertainty about whether the rally can hold.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMCs reported discussions with Elon Musks Terafab project are drawing attention, with traders weighing the prospect of a Texas manufacturing role against Musks caveat that talks are preliminary and no deal is finalized; some note Intel remains the projects named primary partner. The speculation is adding to bullish chatter around TSMCs breakout and its central role in meeting strong AI-chip demand.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zetas agreement to acquire Digital Audience is drawing attention alongside CEO David Steinbergs bullish CNBC remarks about customer business generated by Zeta Live. Bulls see the acquisition as expanding the companys AI-driven data and marketing reach, while some traders warn of profit-taking and acquisition or dilution risks.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate is under pressure after reports that Toshiba plans to expand HDD capacity for AI data centers, prompting concerns that added competition could weaken the tight-supply and pricing-power story behind the storage rally. Traders are divided between expecting a lasting competitive threat and calling the selloff an overreaction, arguing that strong demand and a gradual capacity ramp may limit the near-term impact.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Discussion centers on claims that Igloo is winding down Abstract: some traders see a possible shift of focus back to Pudgy Penguins and PENGU as bullish, while others criticize Luca and voice concerns about token sales or a rug. The conversation also reflects mixed sentiment around PENGUs price weakness, with speculative calls for a rebound alongside frustration over selling pressure.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Anthropics report of discovering a CRISPR-like enzyme system has prompted concern about competition across gene-editing stocks, including CRSP. Traders disagree on its significance: some see a possible long-term challenge, while others emphasize that its function remains unknown and that it does not pose a clear near-term threat to CRSPs clinical programs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million.
Aethlon Medical (NASDAQ:AEMD) shares moved upwards byread more...

Biotech Bombshells and AI Power Plays: The Stocks Suddenly Turning Heads

Today’s market action is being driven by hard catalysts. Quoin Pharmaceuticals (NASDAQ:QNRX) has fresh interim clinical data; NeOnc Technologies Holdings (NASDAQ:NTHI) has moved its NEO100 story toward an FDA registration discussion; FingerMotion (NASDAQ:FNGR) is attempting a major strategic pivot toward AI infrastructure; and Solstice Advanced Materials (NASDAQ: SOLS) has replaced a transformative merger with a $500 million buyback and an independent-growth narrative. Meanwhile, Gap (NYSE: GAP) is demonstrating that a mature consumer company can still generate sharp divergence between individual brands.

Quoin Pharmaceuticals Stock Surges Friday: What's Happening?

Shares of Quoin Pharmaceuticals are rallying Friday after pre-market updates on positive trial results and a major institutional financing.read more...

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers

Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-market session. The company's market cap stands at $10.3 million.
Aethlon Medical (NASDAQ:AEMD) stock moved upwards byread more...

Quoin’s Netherton Data Turns Heads and Could Make QRX003 Breakout Catalyst

Quoin Pharmaceuticals (NASDAQ:QNRX) delivered the kind of interim clinical signal that can abruptly change the conversation around a small-cap biotech: its investigational QRX003 lotion produced statistically significant improvements in key measures of Netherton Syndrome in the first six patients to complete 12 weeks of treatment. The company says four of six participants, or 66.7%, achieved at least a one-grade improvement on the Investigator Global Assessment, producing a p=0.0087 result that cleared the study’s pre-specified interim alpha of 0.0215.

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-market session. The market value of their outstanding shares is at $8.8 million.
Mobile-health Network (NASDAQ:MNDR)read more...

Quoin Pharmaceuticals Garners Buzz After FDA’s Comments On Netherton Syndrome Lead Drug

Equity

The U.S. Food and Drug Administration indicated that a single Phase 3 trial of QRX003 could be enough to support approval in the U.S.

Quoin Pharmaceuticals Gains FDA Alignment, Eyes Streamlined Path to First Netherton Syndrome Treatment

Quoin Pharmaceuticals (NASDAQ:QNRX) reported a key regulatory milestone following a constructive Type C meeting with the U.S. Food and Drug Administration (FDA), potentially accelerating the development path for its lead candidate, QRX003, in the treatment of Netherton Syndrome, a rare and underserved genetic skin disorder.

QNRX Stock Soared A Whopping 39% Today: What’s Driving The Relentless Rally? 

A rapamycin loading concentration of 4% w/w has been achieved for Quoin’s topical formulation, while an even higher concentration of 5% w/w has been formulated in a dermal patch system, the company said.

QNRX Stock Soars 300% After $104.5M Financing Through Private Placement

Quoin said that the purchase agreement also includes an initial upfront funding of $16.5 million and up to an additional $88 million upon the potential cash exercise of accompanying warrants at the election of the investors.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$QNRX Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome 
GLOBENEWSWIRE 7:30 AM ET 9/8/2026

$QNRX Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Day Trader

Looking for a good free small caps community to share ideas and find runners early?      
     
Make sure to click below. Amazing group of bulls 🔥   
 
$QNRX $RILY in these

Tan man

$QNRX who remember when this ran feom 8>21$ last year. hopefully another similar run comes along

Ming

$QNRX Lake Street Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20 
BENZINGA 9:23 AM ET 9/23/2026  
 
Lake Street analyst Thomas Flaten initiates coverage on Quoin Pharmaceuticals(QNRX) with a Buy rating and announces Price Target of $20.

$QNRX Quoin Pharmaceuticals Says FDA Granted Fast Track Designation To QRX003 For Peeling Skin Syndrome 
BENZINGA 7:33 AM ET 9/22/2026

$QNRX and the optionality the ~zero EV ignores just got bigger: FDA granted a SECOND Rare Pediatric Disease Designation (PSS, on top of Netherton) — two potential PRVs, which per mgmt could be >$300M in non-dilutive cash if approved. That's 7x the current market cap in vouchers alone, separate from any drug revenue. Still contingent on approval — but it's all priced at zero right now.

John Svipe

$QNRX Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

QNRX Quoin Pharmaceuticals Ltd - ADR